Navigation Links
Biomatrica and USAMRIID Sign a CRADA for the Development of New Technologies Applicable for Ambient Stabilization of Clinical and Biological Samples
Date:7/28/2011

SAN DIEGO, July 28, 2011 /PRNewswire/ -- Biomatrica, Inc., the leader in room temperature sample storage and stabilization, and the US Army Medical Research Institute of Infectious Diseases (USAMRIID), today announced the signing of a Cooperative Research and Development Agreement (CRADA) to develop room temperature solutions for managing clinical and biological samples.

The two organizations will collaborate on the development, testing, validation and eventual commercialization of new formulations designed to stabilize clinical samples and biological agents at ambient conditions. Current cold chain-based systems are costly, and can have significant logistical challenges on the battlefield, hence a need to store and preserve these materials at ambient conditions without frozen sample shipping and storage.

The CRADA collaboration was initiated after preliminary investigation of stabilization reagents developed at Biomatrica identified very promising stabilizers of biological samples with potential for improving diagnostic capabilities. This collaboration is now extended to cover new and novel formulations being developed at Biomatrica that will support scientific research of benefit to the US military.

Extensive research has been conducted in USAMRIID's laboratories to test several formulations developed by Biomatrica. Results have been encouraging, and the CRADA project continues this collaborative research effort in developing new formulations targeting the stabilization and clinical use of biological samples of importance to USAMRIID's mission.

"We are very excited to see the application and use of our technologies within the US military and are looking forward to getting some of these new technologies commercialized for broader use in clinical and diagnostic research that also has an immediate benefit to molecular diagnostics and the field of personalized medicine," says Dr. Rolf Muller, President and Chief Scientific Officer of Biomatrica, who is a co-PI on the CRADA project.

About Biomatrica, Inc.

Biomatrica (www.biomatrica.com) is a San Diego-based biostability company that provides innovative technologies for stabilizing, processing, storing, shipping and assaying biological samples at room temperature. The core technology is designed for use in preserving complex biological samples and assays and is based on the principles of anhydrobiosis ("life without water"), a natural mechanism that allows multicellular organisms to survive extreme environments. Biomatrica's current products stabilize DNA and RNA with no sample degradation, thus labs can reduce their reliance on freezers and drastically reduce shipping costs. Biomatrica products are used in laboratories performing life science research, from pharmaceutical and biotechnology companies to academic research and forensics laboratories. Custom services to stabilize additional sample types such as proteins are also available. Biomatrica also offers SampleWare® software, an easy-to-use, customizable laboratory management database that provides scientists with the means to store and organize their sample data, and directly supports samples stabilized by Biomatrica technology. For more information about the SampleMatrix technology and the Biomatrica products utilizing this  technology platform (DNAstable® and DNAgard™ for DNA, RNAstable® for RNA and CloneStable® for bacterial DNA, PCRboost, and STRboost), visit: http://www.biomatrica.com/ or call 1-866-379-6879.

About USAMRIID

USAMRIID, located at Fort Detrick, Maryland, is the lead medical research laboratory for the U.S. Department of Defense's Biological Defense Research Program, and plays a key role in national defense and in infectious disease research. The Institute conducts basic and applied research on biological threats resulting in medical solutions (such as vaccines, drugs and diagnostics) to protect the warfighter. While USAMRIID's primary mission is focused on the military, its research often has applications that benefit society as a whole. USAMRIID is a subordinate laboratory of the U.S. Army Medical Research and Materiel Command. For more information, visit www.usamriid.army.mil

[The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.]


'/>"/>
SOURCE Biomatrica, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture
2. Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature
3. Biomatrica Secures Strategic Investment from IQT
4. Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
5. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
6. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
7. Promising Cystic Fibrosis Compound on Track for Development
8. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
9. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
10. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Divoti USA will engrave and process all non-coated stainless ... FDA requirements, which stipulates new criteria regarding medical device manufacture and ... ID jewelry such as Medical ID Bracelets, can rest assured that ... the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving process with ...
(Date:10/11/2017)... , Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: ... that developed an innovative way to use nonlinear optical ... delivery of new drugs. ... Dermatology Conference will show how researchers from BioPharmX and ... Medical School used a suite of imaging techniques in ...
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
Breaking Medicine Technology:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has released a ... books in the Holy Scriptures, Revelation. The Book of Revelation paints a picture of ... have tossed it off as mere rubbish, but Yisrayl Hawkins says that is because ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
Breaking Medicine News(10 mins):